Globally Recognized Nephrologist Joins Dicerna™ to Support Continued Development of DCR-PHXC for the Treatment of Primary Hyperoxaluria
by
Dicerna™ Hires Industry Veterans to Lead Regulatory Affairs and Patient Advocacy
Dicerna™ Appoints Rob Ciappenelli Chief Commercial Officer
Dicerna™ Bolsters Leadership Team to Support Continued Growth
